The firm will lease 79,000ft² of the Parkway 66 property at 7413 Cushing Road in Manassas to construct packaging lines and clean rooms to package and ship medications
The new plant is expected to create 57 new jobs. (Credit: Granules India Limited.)
Pharmaceutical company Granules India is set to invest $12.5m to build a new pharmaceutical packaging facility in Prince William County in the US state of Virginia.
The firm will lease 79,000ft² of the Parkway 66 property at 7413 Cushing Road in Manassas to construct packaging lines and clean rooms to package and ship medications.
The latest plant will be part of the Granules’ Consumer Health division and will return previously outsourced services in-house.
Virginia defeated Maryland in a competitive bid for the project, which will create 57 new jobs.
Prince William County and the Virginia Economic Development Partnership collaborated to win the project for Virginia. Additionally, Former Governor Northam approved a $200,000 grant from the Commonwealth’s Opportunity Fund to assist Prince William County with the project.
Virginia Governor Glenn Youngkin said: “Virginia continues to attract pharmaceutical manufacturing, and Granules India’s new packaging operation in Prince William County is an important addition to the pharmaceutical ecosystem in the Commonwealth.
“The company’s decision to expand its footprint in Virginia is a testament to our infrastructure and robust workforce, and we look forward to further development of this partnership.”
Headquartered in Hyderabad, India, Granules India is a vertically-integrated pharmaceutical company with eight manufacturing facilities around the world. It serves top brand and generics firms in over 75 countries.
The business produces finished dosages, pharmaceutical formulation intermediates, and active pharmaceutical components. Its products include over-the-counter medications like acetaminophen, ibuprofen, and guaifenesin.
The firm also has a pharmaceutical R&D and production plant in Fairfax County where 130 people work.
Granules India founder and managing director Dr Krishna Prasad Chigurupati said: “The addition of a US packaging facility will result in Granules being among the few pharmaceutical companies to be vertically integrated from API to packaging, which will bolster the robustness of Granules’ supply chain while also enabling the company to react even faster to consumers’ growing needs for pharmaceutical products.”